Bond LSC Research // Bond Life Sciences Center

July 25, 2022

Chemical Correspondence: MU researcher plays key role in overseas aptamer technology

By Cara Penquite | Bond LSC Donald Burke is a principal investigator at the Bond Life Sciences Center. He is a professor of molecular microbiology and immunology and a joint professor of biochemistry. Photo by Lauren Hines | Bond LSC What started as an email correspondence between two aptamer enthusiasts rapidly snowballed into a hat…

June 20, 2022

A Dual Focus: MU researcher earns $181,734 NIH grant and U.S. Public Health Service Award for COVID-19 research in the lab and on campus

By Cara Penquite | Bond LSC Cynthia Tang is an M.D.-Ph.D. student in the Wan lab. Photo by Cara Penquite | Bond LSC Cynthia Tang’s academic career is marked by her propensity to multitask. From earning a major and three minors during her undergrad to making a documentary while getting lab and clinical experience, she…

June 6, 2022

Seeing the bigger picture through applied research projects

Investigators at Bond LSC take steps to apply basic research By Cara Penquite | Bond LSC Photo by Lauren Hines | Bond LSC Scribbling in a lab notebook and planning experiments tucked between shelves of equipment, it’s easy to fixate on day-to-day lab operations. But scientists also face the challenge of finding how research can…

April 20, 2022

Protein or Poison? Research into seed composition shows potential uses as protein source or insecticide

Hari Krishnan holds a handful of A. pavonina seeds. Known for their bright color, the seeds are known among many Asian and African communities as coming from the red bead tree. Photo by Cara Penquite | Bond LSC By Cara Penquite | Bond LSC An energetic and fulfilling day starts with a spread of healthy…

April 13, 2022

Receptors Found to Help Patients with Sjögren’s Disease

The Baker lab poses for a group photograph. The lab has been working with specialized pro-resolving lipid mediators in efforts to help patients with Sjögren’s Disease. Photo by Karly Balslew, Bond LSC By Karly Balslew | Bond LSC Saliva is probably not the first thing that comes to mind when we think about eating our…

March 16, 2022

Competing with COVID: Researcher suggests varying from vaccines to fight virus

COVID-19 virus particles have spike proteins, represented in red, that attach to receptors on host cells. Antivirals block the receptors on host cells so the virus cannot infect more cells. | Creative Commons Photo By Cara Penquite | Bond LSC Vaccines were the light at the end of the tunnel throughout the COVID-19 pandemic, but…

March 3, 2022

Protecting Plants: Researchers identify genes responsible for vital antimicrobial proteins

DNA is the genetic material that determines the characteristics of plants and animals. Using CRISPR gene editing, researchers altered the characteristics of rice plants. | Creative Commons Photo by Pixabay By Cara Penquite | Bond LSC A tickle in the throat, a stuffy nose, congestion . . . the tell-tale signs of a cold are…

Feb. 24, 2022

Another piece of the pathway: Stacey lab identifies enzyme key to regulating plant metabolism

Researcher Sung-Hwan Cho holds mutant Arabidopsis thalianas. The Gary Stacey lab used these mutant variations to study how plants react to external stressors. | Photo by Karly Balslew, Bond LSC By: Karly Balslew | Bond LSC When we get hurt, our body signals our brain to warn us about stress and damage. We acknowledge the…

Feb. 17, 2022

Pancreatic tumor composition provides insight on treatment response

Jing Zhou focuses the microscope through her computer. The microscope feeds its view directly to her screen so Zhou can see the pancreatic cells. | Photo by Cara Penquite, Bond LSC By Cara Penquite | Bond LSC Not all tumors are created equal, and potential treatments aren’t universal. When it comes to pancreatic cancer, surgery…

Feb. 9, 2022

Old Drugs, New Application: Artificial Intelligence Aid Future Breast Cancer Treatment

Photo by Christina Victoria Craft on Unsplash By Karly Balslew | Bond LSC New drug treatments take time and money to develop, especially with diseases as complicated as cancer. Developing a new drug to help cancer patients can take up to fifteen years and can cost roughly $1.6 billion, according to a paper published in…

Christopher S. Bond Life Sciences Center

University of Missouri